Intedeukin (IL) 2-deficient mice develop a fatal immunopathology characterized by lymphadenopathy, splenomegaly, T cell infiltration of the bone marrow, loss of B cells, anemia, and inflammation of the gut. The thymus dependence of these disease symptoms was tested by introducing the IL-2 mutation into athymic mice. With the exception of an increase in CD8+ intrahepatic oLlp T cells, IL-2 deficiency had no detectable effect on leukocyte composition or health of athymic mice, indicating a key role for thymus-derived T cells in the initiation of disease and demonstrating that B cell development and survival are independent of IL-2. In adoptive transfer studies, lymph node and spleen cells from euthymic IL-2-deficient mice induced disease in athymic mice with an intact IL-2 gene, suggesting that thymus-independent IL-2-expressing cells are unable to control the development of immune pathology . Both IL-2+ and IL-2 -' -bone marrow cells repopulated the thymus and the peripheral T cell compartment of the recombination activator gene 2-deficient recipients, and chimeras that had received IL-2-deficient bone marrow developed immune pathology . Disease development was, however, fully or at least partially prevented when 30% ofthe bone marrow inoculum was derived from mice able to express IL-2. These results demonstrate that the IL-2 deficiency syndrome depends on the intrathymic differentiation ofT cells carrying the IL-2 mutation, and that the abnormal activation of IL-2-deficient lymphocytes can be controlled by thymus-derived but not thymusindependent lymphocytes .
Summary
Intedeukin (IL) 2-deficient mice develop a fatal immunopathology characterized by lymphadenopathy, splenomegaly, T cell infiltration of the bone marrow, loss of B cells, anemia, and inflammation of the gut. The thymus dependence of these disease symptoms was tested by introducing the IL-2 mutation into athymic mice. With the exception of an increase in CD8+ intrahepatic oLlp T cells, IL-2 deficiency had no detectable effect on leukocyte composition or health of athymic mice, indicating a key role for thymus-derived T cells in the initiation of disease and demonstrating that B cell development and survival are independent of IL-2. In adoptive transfer studies, lymph node and spleen cells from euthymic IL-2-deficient mice induced disease in athymic mice with an intact IL-2 gene, suggesting that thymus-independent IL-2-expressing cells are unable to control the development of immune pathology . Both IL-2+ and IL-2 -' -bone marrow cells repopulated the thymus and the peripheral T cell compartment of the recombination activator gene 2-deficient recipients, and chimeras that had received IL-2-deficient bone marrow developed immune pathology . Disease development was, however, fully or at least partially prevented when 30% ofthe bone marrow inoculum was derived from mice able to express IL-2. These results demonstrate that the IL-2 deficiency syndrome depends on the intrathymic differentiation ofT cells carrying the IL-2 mutation, and that the abnormal activation of IL-2-deficient lymphocytes can be controlled by thymus-derived but not thymusindependent lymphocytes . I L-2, originally described as T cell growth factor, has pleiotropic effects on the proliferation and differentiation ofT, B, and NK cells . In addition, inhibition of T cell development by antibodies to the of chain of the IL-2 receptor (IL-2R) reported by some (1, 2) but not by other investigators (3) had suggested an essential role for IL-2 in intrathymic T cell maturation. Unexpectedly, however, mainstream T cell development in mice with a disrupted IL-2 gene is normal (4) , and after 3-4 wk of age, peripheral T cells are even increased in number and display an activated phenotype. This marks the onset of a lethal syndrome characterized by splenomegaly and lymphadenopathy, an early burst ofB cell activation followed by their virtual disappearance, T cell infiltration of the bone marrow, anemia, autoantibody production, and a severe colitis preceded by an infiltration of the gut epithelium with CD4 and CD8 ot/(3 T cells (5) (6) (7) (8) . Hyperactivation of T cells and development of autoimmunity have also been observed in mice lacking the IL-2R/3 chain (9), supporting the concept that IL-2R-mediated signals are required for the containment of T cell activation in vivo. Among the mechanisms that could lead to the development ofthe symptoms listed above are an incomplete deletion of autoreactive clones in T cell ontogeny, unchecked lymphocyte activation caused by a disturbance of the cytokine network, physical or functional absence of specialized suppressor cells, and a requirement for IL-2 in limiting clonal growth by predisposing mature activated T cells toward apoptotic death (10) . In addition, breakdown of the B cell compartment could either result from T cell-mediated destruction or from an impaired replenishment ofthe peripheral pool from precursors expanded by IL-2, a possibility suggested by the expression of the IL2Rot chain on pro-B cells (11) . So far, attempts at identifying defects in T cell repertoire selection have yielded negative results (12) . With regard to a breakdown in peripheral regulation, the delayed onset of immunopathology in germfree IL-2-deficient mice suggests that an antigen trigger is required to drive the abnormal lymphoproliferation observed (6) . Since the oligoclonal repertoire ofathymic mice allows alloreactive but not self-MHC-restricted T cell responses to environmental antigens (13) (14) (15) (16) , the IL-2 mutation was introduced into nulnu mice to ask whether thymus-processed T cells (with a diverse repertoire) are required to initiate disease, including the destruction of B cells and bone marrow cells . Furthermore, it remained to be formally proven that lack of IL-2 expression in bone marrowderived cells suffices for the development of the IL-2 deficiency syndrome. Therefore, recombination activator gene (RAG)' 2-deficient mice repopulated with H-2-matched bone marrow from IL-2 -'-mice were investigated for signs of disease. Finally, the simultaneous transfer of IL-2+ and IL-2 -bone marrow into RAG-2-deficient recipients was used to address the question of whether autocrine production of IL-2 is required for the control of clonal expansion or whether IL-2-producing or -dependent bystander cells could interfere.
Materials and Methods
Mice . IL-2`mice from a mixed C57BL/6/H1290LA background (4) were back-crossed for four generations to C57BL/6 mice . After mating with C57BL/6 nu/nu mice, IL-2`mice were identified by PCR among the nude offspring of the F2 generation. Euthymic IL-2"+ and IL-2+/ -mice (which are phenotypically identical and will be referred to as IL-2+) were used as controls . RAG-2`H-2b mice were originally generated by Shinkai and colleagues (17) . These and B6 Ly5.2-congenic mice (following the original nomenclature used for derivation of congenic strains and mAbs [18] ) were kindly provided by Dr. H. R. ' Abbreviations used in this paper: BSS, balanced salt solution ; IEL, intraepithelial lymphocytes ; RAG, recombination activator gene . Rodewald, Basel Institute for Immunology, Basel, Switzerland) . All animals were bred in a barrier-sustained facility and were found free of common pathogens.
Preparation and Transfer of Cells.
Cells from thymus, lymph nodes, and spleen were prepared by grinding organs through a stainless steel sieve into ice-cold balanced salt solution (BSS). To prepare intraepithelial lymphocytes, the small intestine was opened longitudinally in PBS, and Peyer's patches were removed. Small pieces of the residual tissue were treated with Ca/Mg-free BSS/1 mM dithiothreitol for 20 min and with RPMI-1640/10% FCS for 40 min at 37°C. Filtered cells were enriched for lymphocytes by Percoll-gradient centrifugation. Hepatic mononuclear cells were prepared by injecting PBS into the portal vein to remove circulating cells from the liver before dissecting the animal . The tissue was then crushed and washed twice with BSS. Lymphocytes were enriched by Ficoll-gradient centrifugation . Bone marrow was ejected from femur and tibia of hind legs by injecting BSS. Bone marrow cells were washed twice with BSS. In the case of euthymic bone marrow donors, cells were further depleted of Thy-1+ cells by a magnetism-activated cell sorter (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany) . To reconstitute RAG-2-deficient mice, 2 X 10' BM cells, and for transfer into nu/nu mice, 5 X 10' lymph node and spleen cells (1 : 1), were injected intravenously.
Antibodies and Flow Cytometry.
The following antibodies were used : PE-conjugated anti-CD4 (clone H129 .19; Becton Dickinson & Co ., Mountain View, CA), biotinylated or FITC-conjugated anti-CD8a (clone 53-6 .7 ; Boehringer Mannheim GmbH, Mannheim, Germany), PE-conjugated anti-B220 (clone RA3-6B2; Serva, Heidelberg, Germany), and FITC-conjugated anti-a[3Tcr (clone H57-597; PharMingen, San Diego, CA). . FITC-conjugated anti-Ly5 .1 (clone 104.2 .1), and biotinylated anti-Ly5 .2 (clone A20-1.7) (18) were kindly provided by Dr. H. R. Rodewald .
For two-or three-color flow cytometry, 2 X 10 5 cells in 0.1 ml PBS/0.1% BSA/0.02% sodium azide were stained with the biotinylated antibody for 15 min on ice, washed, and incubated for 15 min on ice with streptavidin redb'°(Life Technologies GmbH, Eggenstein, Germany), the FITC-labeled mAb, and/or the PE-conjugated mAb . All antibodies were used at saturating concentrations . Flow cytometry was performed with a FACScan°f low cytometryr using Lysys II software (Becton Dickinson & Co .) . Results are shown as log-log dot plots or as histograms .
Results
Thymus Dependence of the IL-2 Deficiency Syndrome .
Both the nu and the IL-2 -mutation were bred to homozygosity into the C57BL/6 background. Athymic IL-2-deficient mice appeared healthy and, in contrast of their euthymic littermates, showed no increased mortality. Even at >6 mo of age, a time point where few euthymic IL-2 -/-mice survive, none of the pathological alterations regularly observed in IL-2`euthymic mice were found.
As shown in Fig. 1 A, cellularity of spleens remained normal in athymic IL-2 -'-mice, whereas their euthymic littermates developed severe lymphadenopathy (not shown) and splenomegaly, as previously described (5, 6) . Moreover, the loss of splenic B cells (Fig . 1 B) and mature B cells from the bone marrow (Fig . 2) , which follows initial polyclonal T and B cell activation in euthymic IL-2 -~-mice, was not observed in athymic IL-2-deficient mice, suggest-ing that uncontrolled activation of thymus-derived T cells is crucial for B cell depletion . Similarly, infiltration of the bone marrow with mature T cells, which is likely to play a role in the loss ofB cells and development o£ anemia in euthymic IL-2-'-mice, did not occur in IL-2-deficient athymic mice (Fig. 2) . Importantly, adoptive transfer ofperipheral lymphocytes from IL-2-' -but not from IL-2+ C57BL/6 mice into athymic IL-2 + C57BL/6 mice, caused T cell infiltration of the bone marrow (Fig. 2) and loss ofB cells from bone marrow and spleen (not shown) .
One of the key symptoms of the IL-2 deficiency syndrome is inflammatory bowel disease with fatal outcome (6) . The onset of colitis is preceded by an infiltration of the gut epithelium with CD4 T cells, which represent a minority among normal intestinal intraepithelial lymphocytes (IEL) . None of the athymic IL-2-' -mice developed overt colitis, and even at the more sensitive level ofT cell subset composition, no significant effects of the IL-2 mutation were observed (Fig. 3) . As shown above for the bone marrow, transfer of peripheral lymphocytes from euthymic IL-2 -'-but not from IL-2+ mice resulted in infiltration of the gut epithelium with CD4 T cells (Fig. 3) .
In summary, development of the IL-2 deficiency syndrome depends on an intact thymus, indicating that destruction ofB cells and bone marrow cells as well as development ofcolitis are initiated by thymus-derived T cells, and that thymus-independent T cell lineages do not mediate immune pathology ifdeprived ofIL-2 . Furthermore, thymus-independent cells expressing an intact IL-2 gene are unable to control the abnormal activation of thymus-derived IL-2-'-T cells, at least under the conditions of adoptive transfer used here.
Intrahepatic T Celts in Athymic IL-2-'-Mice.
Aging athymic mice contain variable numbers of T cells in their peripheral lymphoid organs, probably because of the expansion of few T cell clones from a small number ofprecursors (13) (14) (15) (16) . Based on phenotypic similarities such as a reduced level of TCR expression between hepatic T cells of euthymic mice (19) and peripheral T cells found in athymic mice (20, 21) , the liver has been proposed as a site of extrathymic T cell differentiation (19, 22) . On the other hand, the absence of RAG transcripts in the liver and influx of preapoptotic activated peripheral T cells that acquire the phenotype of liver T cells has argued against this view and has suggested a role for the liver in the elimination ofactivated T cells (23, 24) . When T cell subsets were compared in spleens and lymph nodes of IL-2+ and IL-2-'-C57BL/6 nu/nu mice, no differences beyond the individual variability also found in IL-2+ athymic mice were observed (data not shown) . Thymus dependence of CD4 T cell infiltration in the epithelium of the small intestine of IL-2-deficient mice . Flow cytometric analysis of intestinal IEL from IL-2 + and IL-2-1-euthymic (top) and athymic (center) C57BL/6 mice, and from IL-2 + athymic mice injected 6 wk previously with 5 X 107 peripheral lymphocytes from 4-wk-old IL-2+ or IL-2`C57BL/6 mice . deficiency . Thus, the total number of recovered mononuclear cells (Table 1 ) and the frequency of a/R T cells with a reduced level of TCR expression (TCRint cells ; Fig . 4 A) , which is characteristic of T cells in the liver, was stron Table 1 . Number of Intrahepatic Mononuclear Cells Isolated from the Livers of IL-2 + and IL-2 -1-Euthymic and Athymic Mice y *Mononuclear cells were isolated as described in Materials and Methods, and viable cells were counted by trypan blue exclusion. increased in both euthymic and athymic C57BL/6 mice carrying the IL-2 mutation compared with their IL-2+ littermates . This increase in T cell number was primarily caused by CD4 -8 + cells (Fig . 4 B) To analyze whether the control of T cell activation that breaks down in IL-2-deficient mice requires autocrine regulation by IL-2 or can be exerted by IL-2-expressing cells (providing IL-2 in a paracrine fashion or acting as specialized suppressor cells), RAG-2 -'-mice were coinjected with 70% IL-2 -' -and 30% Ly5 .2-marked IL-2+ bone marrow cells . When analyzed 6 wk after transfer, the ratio of Ly5 .1-and Ly5 .2-expressing lymphocytes was similar (7 :3) in the thymus and in peripheral lymphoid organs of the reconstituted animals . Importantly, three of four chimeras appeared healthy 6 wk after transfer, and only one had an abnormally increased size and cellularity of spleen and lymph nodes along with red cell destruction in the bone marrow . Neither T cell infiltration nor red cell destruction were observed in the bone marrow of the remaining animals ( Table 2 and Fig . 5 ) . Overrepresentation of CD4 + cells among intestinal IEL was found in one additional mouse, which, however, remained free of diarrhea or overt colitis. These results show that to a large extent, T cells capable of producing IL-2 are able to contain the dysregulated activation of IL-2-deficient T cells that leads to the development of the IL-2 deficiency syndrome in RAG-2 -1-mice restored with IL-2 -1-bone marrow cells . The hallmark of the inflammatory and autoimmune manifestations of the mouse IL-2 deficiency syndrome is a hyperactivation of T cells, which precedes all other symptoms described above and, according to the present results, is likely to be the key event in the development of immune pathology . Thus, athymic mice carrying the IL-2 mutation remain free of bone marrow atrophy and red cell destruction, maintain normal B cell numbers, and do not develop colitis. Consequently, a direct effect of IL-2 deficiency on the survival of bone marrow stem cells and on the generation and maintenance of their B cell and erythrocyte progeny can be excluded. Furthermore, the thymus-independent T cell lineages originating in the gut epithelium do not mediate the inflammatory response found at that site in euthymic IL-2-deficient animals . In contrast, peripheral T cells transferred into nude mice from IL-2-1-donors infil- trate the gut and the bone marrow, supporting the conclusion that thymus-derived T cells are responsible for disease development .
The only difference detected in IL-2-deficient athymic mice compared with their IL-2+ littermates was a numeric increase in hepatic T cells that displayed the TCR'°`phenotype found on the majority of hepatic T cells in normal mice and on T cells in both lymphoid organs and liver of athymic mice. This increase was mainly caused by CD4 -8+ cells, which were also severalfold expanded in the liver of euthymic IL-2-deficient mice compared with IL-2+ controls . We have previously reported that among the small subset of ot/(3TCR'°tIL-2R(3 + thymocytes, which in normal mice are predominantly CD4 -8-, IL-2 deficiency also causes a marked skewing toward the CD4 -8+ phenotype (25) . Such oc/(3TCR'n1IL-2R(3+ T cells in the thymus and RAG-2-'-mice were injected intravenously with a total of 2 X 107 bone marrow cells (for details see legend to The resemblance of the IL-2 deficiency syndrome to some features of GVHD has prompted an earlier search for a defect in negative repertoire selection in these animals (12) . Neither central deletion of V(3-defined T cell subsets by endogenous superantigens nor its acute induction by peptide administration in an MHC class I-restricted TCRtransgenic model, however, revealed any obvious effects of the IL-2 mutation. We thus favor the view that disease is initiated by an uncontrolled peripheral activation of T cells with a "normal" repertoire, rather than an increased escape of autoreactive T cells from intrathymic deletion . This uncontrolled activation is most likely driven by environmental antigens since athymic mice, which do contain functional T cells, albeit with a very restricted repertoire (13-16), do not develop disease . This conclusion is further supported by the delayed onset ofinflammatory bowel disease in mice with a reduced antigenic environment (6) .
As shown by cotransfer o£ IL-2-1-and IL-2+ bone marrow into RAG-2-deficient mice, the simultaneous presence of lymphocytes with an intact IL-2 gene can greatly attenuate the development ofthe IL-2 deficiency syndrome. Therefore, IL-2-deficient mice either lack a specialized immunoregulatory cell population that depends on IL-2 for its development or function, or IL-2 provided in an auto-Kramer et al.
crine or paracrine fashion is required for the termination of clonal expansion by apoptosis, as has been suggested by Lenardo (10) . Indeed, recent results indicate that activated T cells from IL-2-deficient mice are more resistant to Fasinduced apoptosis than those from IL-2 wild-type mice (30) . On the other hand, IL-2 could also be required for the induction of cytotoxic activity in CD8 T cells, which, as suggested by recent experiments by Jiang and colleagues (31) , might eliminate clonally expanded CD4 T cells (which are the main population that expands in peripheral lymphoid organs ofIL-2-deficient mice) . Although antiviral CTL responses have been observed in IL-2-deficient mice (32) , this seems to be a viable explanation since in a TCR-transgenic model, peptide immunization has revealed a stringent requirement for IL-2 in the induction of CTL effector function (12) , raising the possibility that the proposed TCRspecific CTL responses required for the containment ofCD4 T cell expansion are suboptimal in IL-2-deficient mice.
Whatever the mechanism by which IL-2R-mediated signals limit T cell activation in vivo, it seems unlikely from the present experiments that thymus-independent leukocyte populations are, by themselves, able to control the excessive activation of IL-2-deficient thymus-dependent T cells . Thus, despite the presence of NK cells and extrathymically derived T cells in athymic mice, IL-2-'-T cells initiated the characteristic symptoms of the IL-2 deficiency syndrome upon cell transfer . Further experiments will be aimed at identifying the subset of thymus-derived T cells with the most "curative" effect and to elucidate whether they contain T cell hyperactivation via paracrine IL-2 delivery or through the action ofa specialized suppressor cell.
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